BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23848395)

  • 1. Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum.
    Qidwai T; Priya A; Khan NA; Tripathi H; Khan F; Darokar MP; Pal A; Bawankule DU; Shukla RK; Bhakuni RS
    Curr Drug Targets; 2014 Apr; 15(4):374-409. PubMed ID: 23848395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and maintenance of the Plasmodium falciparum apicoplast genome.
    Milton ME; Nelson SW
    Mol Biochem Parasitol; 2016 Aug; 208(2):56-64. PubMed ID: 27338018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apicoplast Metabolism: Parasite's Achilles' Heel.
    Kadian K; Gupta Y; Singh HV; Kempaiah P; Rawat M
    Curr Top Med Chem; 2018; 18(22):1987-1997. PubMed ID: 30499407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apicoplast Import Protein Tic20 A Promising Therapeutic Molecular Target for Plasmodium falciparum: An In Silico Approach for Therapeutic Intervention.
    C P K Srimath-Tirumala-Peddinti R; Kusuma SS; Nammi D; Neelapu NRR
    Infect Disord Drug Targets; 2017; 17(3):199-222. PubMed ID: 28595540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of a Transporter to the Outer Apicoplast Membrane in the Human Malaria Parasite Plasmodium falciparum.
    Lim L; Sayers CP; Goodman CD; McFadden GI
    PLoS One; 2016; 11(7):e0159603. PubMed ID: 27442138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of Apicoplast Biogenesis by Chemical Stabilization of an Imported Protein Evades the Delayed-Death Phenotype in Malaria Parasites.
    Boucher MJ; Yeh E
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30674649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking.
    Kennedy K; Cobbold SA; Hanssen E; Birnbaum J; Spillman NJ; McHugh E; Brown H; Tilley L; Spielmann T; McConville MJ; Ralph SA
    PLoS Biol; 2019 Jul; 17(7):e3000376. PubMed ID: 31318858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets.
    Dousti M; Manzano-Román R; Rashidi S; Barzegar G; Ahmadpour NB; Mohammadi A; Hatam G
    Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33202000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apicoplast as an antimalarial drug target.
    Ralph SA; D'Ombrain MC; McFadden GI
    Drug Resist Updat; 2001 Jun; 4(3):145-51. PubMed ID: 11768328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug.
    Wellems TE
    Science; 2002 Oct; 298(5591):124-6. PubMed ID: 12364789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apicoplast Dynamics During
    Elaagip A; Absalon S; Florentin A
    Front Cell Infect Microbiol; 2022; 12():864819. PubMed ID: 35573785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.
    Uddin T; McFadden GI; Goodman CD
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum.
    Dahl EL; Shock JL; Shenai BR; Gut J; DeRisi JL; Rosenthal PJ
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3124-31. PubMed ID: 16940111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
    Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multifunctional autophagy pathway in the human malaria parasite, Plasmodium falciparum.
    Cervantes S; Bunnik EM; Saraf A; Conner CM; Escalante A; Sardiu ME; Ponts N; Prudhomme J; Florens L; Le Roch KG
    Autophagy; 2014 Jan; 10(1):80-92. PubMed ID: 24275162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.